- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
Total 19608 results
-
NSABP Foundation IncNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
National Cancer Institute (NCI)CompletedMelanoma | Cervical Cancer | Breast Cancer | Renal Cancer | Urothelial CancerUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
UNICANCERPfizer; NanoString Technologies, Inc.Completed
-
Spectrum Pharmaceuticals, IncCompletedBreast Cancer | NeutropeniaUnited States, Canada, Korea, Republic of
-
Spectrum Pharmaceuticals, IncCompletedBreast Cancer | NeutropeniaUnited States, Canada, India, Hungary, Korea, Republic of, Poland
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminated
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
SCRI Development Innovations, LLCCelgene CorporationCompletedBreast CancerUnited States
-
TTY BiopharmActive, not recruiting
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedBreast CancerUnited States
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
NSABP Foundation IncPuma Biotechnology, Inc.CompletedBreast CancerUnited States, Canada, Puerto Rico, Italy, Spain
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
The Netherlands Cancer InstituteRoche Pharma AGCompletedBreast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial CancerNetherlands
-
Damanhour UniversityCompleted
-
Baylor Research InstituteCompletedBreast CancerUnited States
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
M.D. Anderson Cancer CenterEisai Inc.Completed
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
-
Columbia UniversityCompletedBreast Cancer | Locally Advanced Malignant NeoplasmUnited States
-
Centre Leon BerardMerck Sharp & Dohme LLCCompleted
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Sun Yat-sen UniversityTerminatedCarcinoma Breast Stage IVChina
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
University Hospital, GhentWithdrawn
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Thomas Jefferson UniversityWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast CarcinomaUnited States
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
Vejle HospitalCompleted
-
Ian E. Krop, MD, PhDMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital; New...Completed
-
Priyanka SharmaCompletedTriple-negative Breast CancerUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.; International Drug Development InstituteCompleted
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene CorporationCompletedMalignant Neoplasm of BreastGermany
-
University of Wisconsin, MadisonActive, not recruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Breast Cancer | Non-Small Cell Lung Cancer | Meningioma | Hepatocellular CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
UNICANCERCompletedInflammatory Breast Cancer
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States